Abstract A015: A synergistic combination of a novel mTORC1-activator with proteasome inhibitor confers a remission in acute myeloid leukemia
Year: 2024
Type: conference-abstract
Source: Cancer Immunology Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4403520164
